Xxera/openscience/retractions

Record #38761

The Reversible Fourth-Generation EGFR Tyrosine Kinase Inhibitor OBX02-011 Overcomes C797S-Mediated Resistance in Lung Cancer

Journal

Cancer Research

Publisher

American Association for Cancer Research

Original paper date

Jun 14, 2022

Original DOI

10.1158/0008-5472.CAN-22-0394

Country

🇰🇷 South Korea

Institution

Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, South Korea · Department of Biomedical Sciences, Asan Medical Center, AMIST, University of Ulsan, College of Medicine, Seoul, South Korea · Department of Convergence Medicine, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, South Korea · Oncobix, Yongin, South Korea · J2H Biotech, Suwon, South Korea · Department of Pulmonology and Critical Care Medicine, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, South Korea · Department of Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Seoul, South Korea

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (BLS) Biology - Cellular

Citation lifecycle

How this paper is being cited

Pre-retraction

0

Same day

1

Post-retraction

4

% post-retraction

80.0%

~0.0 citations/yr before retraction · ~1.0 citations/yr after

— citing papers

Who is still citing this work

Loading…